Brind.

Analyst price targets affect market sentiment regarding Intuitive Surgical, which is subject to required SEC filings.

1 report, 1 independent Updated Jun 17

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Intuitive Surgical Jefferies Financial Group SEC

Keep exploring

The entities involved

Intuitive Surgical
American corporation
- Citigroup and Baird lowered their stock targets for Intuitive Surgical on October 19, 2026.15:49
- LabCorp is involved in FDA-approved drugs. Intuitive Surgical's systems were FDA-cleared. Masimo develops noninvasive patient monitoring technologies.Sat 14:22
Jefferies Financial Group
American financial services company
- Cantor Fitzgerald and Jefferies Financial Group downgraded EyePoint Pharmaceuticals' stock rating from overweight/buy to neutral/hold on October 19, 2026.17:40
- Royal Bank of Canada reiterated its rating on VAT Group AG, while Jefferies Financial Group upgraded the rating on the Switzerland-based company.09:10
SEC
Slovak company
- MarketBeat monitored consensus ratings for Sasol, and insider transactions related to the company were disclosed to the SEC on May 27, 2026.17:51
- Ledjr AI acquired voting control of SPYR, which must now file a registration statement with the SEC and aims for a Nasdaq listing.15:14

Related events

Analyst targets are being lowered amid new entrants challenging market dominance for medical technology companies.Jul 14

Coverage

Newest first; wire copies grouped

Jun 17tickerreport.com